Lupus Erythematosus Immunostimulatory Molecules In

Total Page:16

File Type:pdf, Size:1020Kb

Lupus Erythematosus Immunostimulatory Molecules In Downloaded from http://www.jimmunol.org/ by guest on September 25, 2021 is online at: average * The Journal of Immunology , 21 of which you can access for free at: 2011; 187:538-552; Prepublished online 25 May from submission to initial decision 4 weeks from acceptance to publication Eneida Villanueva, Srilakshmi Yalavarthi, Celine C. Berthier, Jeffrey B. Hodgin, Ritika Khandpur, Andrew M. Lin, Cory J. Rubin, Wenpu Zhao, Stephen H. Olsen, Matthew Klinker, David Shealy, Michael F. Denny, Joel Plumas, Laurence Chaperot, Matthias Kretzler, Allen T. Bruce and Mariana J. Kaplan 2011; doi: 10.4049/jimmunol.1100450 http://www.jimmunol.org/content/187/1/538 Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus J Immunol cites 65 articles Submit online. Every submission reviewed by practicing scientists ? is published twice each month by http://jimmunol.org/subscription Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts http://www.jimmunol.org/content/187/1/538.full#ref-list-1 http://www.jimmunol.org/content/suppl/2011/05/25/jimmunol.110045 0.DC1 This article Information about subscribing to The JI No Triage! Fast Publication! Rapid Reviews! 30 days* Why • • • Material References Permissions Email Alerts Subscription Supplementary The Journal of Immunology The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2011 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. This information is current as of September 25, 2021. The Journal of Immunology Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus Eneida Villanueva,*,1 Srilakshmi Yalavarthi,*,1 Celine C. Berthier,† Jeffrey B. Hodgin,‡ Ritika Khandpur,x Andrew M. Lin,x Cory J. Rubin,x Wenpu Zhao,* Stephen H. Olsen,‡ Matthew Klinker,* David Shealy,{ Michael F. Denny,*,2 Joel Plumas,‖,#,** Laurence Chaperot,‖,#,** Matthias Kretzler,† Allen T. Bruce,x and Mariana J. Kaplan* An abnormal neutrophil subset has been identified in the PBMC fractions from lupus patients. We have proposed that these low- density granulocytes (LDGs) play an important role in lupus pathogenesis by damaging endothelial cells and synthesizing increased Downloaded from levels of proinflammatory cytokines and type I IFNs. To directly establish LDGs as a distinct neutrophil subset, their gene array profiles were compared with those of autologous normal-density neutrophils and control neutrophils. LDGs significantly overex- press mRNA of various immunostimulatory bactericidal proteins and alarmins, relative to lupus and control neutrophils. In con- trast, gene profiles of lupus normal-density neutrophils do not differ from those of controls. LDGs have heightened capacity to synthesize neutrophils extracellular traps (NETs), which display increased externalization of bactericidal, immunostimulatory pro- teins, and autoantigens, including LL-37, IL-17, and dsDNA. Through NETosis, LDGs have increased capacity to kill endothelial http://www.jimmunol.org/ cells and to stimulate IFN-a synthesis by plasmacytoid dendritic cells. Affected skin and kidneys from lupus patients are infiltrated by netting neutrophils, which expose LL-37 and dsDNA. Tissue NETosis is associated with increased anti-dsDNA in sera. These results expand the potential pathogenic roles of aberrant lupus neutrophils and suggest that dysregulation of NET formation and its subsequent responses may play a prominent deleterious role. The Journal of Immunology, 2011, 187: 538–552. ecent evidence from our group and others indicates that more, lupus patients with higher circulating LDG numbers have neutrophils may play an important role in the induction of increased prevalence of skin involvement and/or vasculitis (1). R autoimmune responses and organ damage in systemic Although currently no specific LDG surface markers have been by guest on September 25, 2021 lupus erythematosus (SLE) (1–3). Furthermore, microarray data identified that would allow them to be distinguished from normal- indicate that neutrophil-specific genes are highly expressed in density granulocytes, their nuclear morphology suggests that these PBMCs from lupus patients because of the cosegregation of low- cells present a more immature phenotype (1, 3). However, it is still density granulocytes (LDGs) in mononuclear cell fractions (3, 4). unknown whether lupus LDGs play prominent roles, when com- These LDGs represent a distinct neutrophil subset that is present pared with normal-density lupus neutrophils, in other aspects of in the peripheral blood of all adult SLE patients analyzed. Lupus disease pathogenesis, including providing a supply of potential LDGs are likely to be pathogenic, given their heightened capa- autoantigens or inducing or perpetuating autoimmune responses city to induce vascular damage and synthesize type I IFNs upon and tissue damage. exposure to specific stimulants, such as G-CSF and polyinosinic: Neutrophils immobilize and kill invading microbes extracellu- polycytidylic acid, when compared with autologous lupus normal- larly through the formation of neutrophil extracellular traps (NETs). density neutrophils and healthy control neutrophils (1). Further- As a unique type of neutrophil cell death, recently described as *Division of Rheumatology, Department of Internal Medicine, University of Mich- (Grant P30 CA46592), the Rheumatic Disease Core Center (Grant P30 AR48310), igan Medical School, Ann Arbor, MI 48109; †Division of Nephrology, Department of and the Applied Systems Biology Core in the O’Brien Renal Center (Grant P30 Internal Medicine, University of Michigan Medical School, Ann Arbor, MI 48109; DK081943). ‡Department of Pathology, University of Michigan Medical School, Ann Arbor, MI x The sequences presented in this article have been submitted to the Gene Expression 48109; Department of Dermatology, University of Michigan Medical School, Ann { ‖ Omnibus under accession number GSE26975. Arbor, MI 48109; Centocor Research and Development, Radnor, PA 19355; Uni- versite´ Joseph Fourier, Grenoble 38041, France; #INSERM U823, Immunobiologie et Address correspondence and reprint requests to Dr. Mariana J. Kaplan, Division of Immunotherapie des Cancers, La Tronche 38706, France; and **Etablissement Fran- Rheumatology, Department of Internal Medicine, University of Michigan Medical cais du Sang Rhone-Alpes, Laboratoire R&D, La Tronche 38701, France School, 5520 MSRBI, 1150 West Medical Center Drive, Ann Arbor, MI 48109-5680. E-mail address: [email protected] 1E.V. and S.Y. contributed equally to the manuscript and share first authorship. The online version of this article contains supplemental material. 2Current address: Division of Rheumatology and Autoimmunity Center, Temple University, Philadelphia, PA. Abbreviations used in this article: ANCA, anti-neutrophilic cytoplasmic Ab; CTSG, cathepsin-G; DEFA4, defensin a-4; EC, endothelial cell; ELANE, elastase-2; IPA, Received for publication February 11, 2011. Accepted for publication April 24, 2011. Ingenuity Pathway Analysis; LCN2, lipocalin-2; LDG, low-density granulocyte; LTF, This work was supported by the National Institutes of Health through Public Health lactotransferrin; MMP-8, matrix metalloproteinase-8; MNase, micrococcal nuclease; Service Grant HL088419 (to M.J.K.), the Arthritis Foundation (to M.J.K.), the Uni- MPO, myeloperoxidase; NET, neutrophil extracellular trap; pDC, plasmacytoid den- versity of Michigan/Centocor Postdoctoral Research Program (to M.J.K. and E.V.), dritic cell; RNP, ribonucleoprotein; SLE, systemic lupus erythematosus; SLEDAI, the Anthony Gramer Fund in Inflammation Research (to M.J.K.), the Babcock Re- systemic lupus erythematosus disease activity index. search Endowment (to A.T.B.), and Training Grant in Cell and Molecular Dermatol- ogy 5T32AR007197 (to C.J.R.). This work was supported in part by the National Copyright Ó 2011 by The American Association of Immunologists, Inc. 0022-1767/11/$16.00 Institutes of Health through the University of Michigan’s Cancer Center Support www.jimmunol.org/cgi/doi/10.4049/jimmunol.1100450 The Journal of Immunology 539 NETosis, this response is distinct from apoptosis and necrosis recognizing human neutrophil elastase (Abcam, Cambridge, MA), human and characterized by the active release of nuclear chromatin fi- Ro/SSA and human La/SSB (Santa Cruz Biotechnology, Santa Cruz, CA), bers (5, 6). NETosis is triggered by a variety of stimuli including mouse Abs recognizing human Smith (Abcam), human Cathelicidin/ OSX12 (Abcam), and human dsDNA (Millipore, Temecula, CA), and microorganisms, proinflammatory cytokines, activated platelets, goat anti-human IL-17 (R&D Systems, Minneapolis, MN) were used. and endothelial cells (ECs) (6, 7). A variety of putative auto- Secondary detection was performed using goat anti-rabbit–FITC (Southern antigens are present within and attached to NET chromatin fibers, Biotechnology Associates, Birmingham, AL), donkey anti-goat Alexa 568 including citrullinated histones (8) and various bactericidal pro- (Invitrogen, Carlsbad, CA), and/or anti-mouse Cy3 (Sigma-Aldrich, St. Louis, MO). Prolong Gold Antifade and Hoechst 33342 were from In- teins and/or enzymes such as the cathelicidin LL-37, neutrophil vitrogen.
Recommended publications
  • Deficiency in Protein Tyrosine Phosphatase PTP1B Shortens Lifespan and Leads to Development of Acute Leukemia
    Author Manuscript Published OnlineFirst on November 9, 2017; DOI: 10.1158/0008-5472.CAN-17-0946 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Deficiency in protein tyrosine phosphatase PTP1B shortens lifespan and leads to development of acute leukemia Samantha Le Sommer1, Nicola Morrice1, Martina Pesaresi1, Dawn Thompson1, Mark A. Vickers1, Graeme I. Murray1, Nimesh Mody1, Benjamin G Neel2, Kendra K Bence3,4, Heather M Wilson1*, & Mirela Delibegovic1* 1Institute of Medical Sciences, University of Aberdeen, United Kingdom 2Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York University, New York, New York 10016, USA. 3 Dept. of Biomedical Sciences, University of Pennsylvania School of Veterinary Medicine, Philadelphia, USA. 4 Current address: Internal Medicine Research Unit (IMRU), Pfizer Inc, 610 Main St. Cambridge, MA 02139 USA *corresponding authors: Prof. Mirela Delibegovic ([email protected]) and Dr. Heather Wilson ([email protected] ) Running Title: PTP1B deficiency shortens lifespan and leads to leukaemia Key Words: PTP1B, lifespan, leukaemia, myeloid, STAT3 Additional information: This work was performed with the funds from the Wellcome Trust ISSF grant to M. Delibegovic and BHF project grant to M. Delibegovic (PG/11/8/28703). S. Le Sommer is a recipient of the University of Aberdeen Institute of Medical Sciences PhD studentship. Conflict of interest: Authors declare there are no conflicts of interests. Word Count: 5,000 Figure Count: 6 Figures, 1 Table (Supplemental Figures: 6, Supplemental Tables: 4) 1 Downloaded from cancerres.aacrjournals.org on September 29, 2021. © 2017 American Association for Cancer Research.
    [Show full text]
  • 1 Evidence for Gliadin Antibodies As Causative Agents in Schizophrenia
    1 Evidence for gliadin antibodies as causative agents in schizophrenia. C.J.Carter PolygenicPathways, 20 Upper Maze Hill, Saint-Leonard’s on Sea, East Sussex, TN37 0LG [email protected] Tel: 0044 (0)1424 422201 I have no fax Abstract Antibodies to gliadin, a component of gluten, have frequently been reported in schizophrenia patients, and in some cases remission has been noted following the instigation of a gluten free diet. Gliadin is a highly immunogenic protein, and B cell epitopes along its entire immunogenic length are homologous to the products of numerous proteins relevant to schizophrenia (p = 0.012 to 3e-25). These include members of the DISC1 interactome, of glutamate, dopamine and neuregulin signalling networks, and of pathways involved in plasticity, dendritic growth or myelination. Antibodies to gliadin are likely to cross react with these key proteins, as has already been observed with synapsin 1 and calreticulin. Gliadin may thus be a causative agent in schizophrenia, under certain genetic and immunological conditions, producing its effects via antibody mediated knockdown of multiple proteins relevant to the disease process. Because of such homology, an autoimmune response may be sustained by the human antigens that resemble gliadin itself, a scenario supported by many reports of immune activation both in the brain and in lymphocytes in schizophrenia. Gluten free diets and removal of such antibodies may be of therapeutic benefit in certain cases of schizophrenia. 2 Introduction A number of studies from China, Norway, and the USA have reported the presence of gliadin antibodies in schizophrenia 1-5. Gliadin is a component of gluten, intolerance to which is implicated in coeliac disease 6.
    [Show full text]
  • Human Cathepsin A/ Lysosomal Carboxypeptidase a Antibody
    Human Cathepsin A/ Lysosomal Carboxypeptidase A Antibody Monoclonal Mouse IgG2A Clone # 179803 Catalog Number: MAB1049 DESCRIPTION Species Reactivity Human Specificity Detects human Cathepsin A/Lysosomal Carboxypeptidase A in direct ELISAs and Western blots. In Western blots, detects the single chain (55 kDa) and heavy chain (32 kDa) forms of recombinant human (rh) Cathepsin A. In Western blots, less than 5% cross­reactivity with rhCathepsin B, C, D, E, L, O, S, X and Z is observed and no cross­reactivity with the light chain (20 kDa) of rhCathepsin A is observed. Source Monoclonal Mouse IgG2A Clone # 179803 Purification Protein A or G purified from hybridoma culture supernatant Immunogen Mouse myeloma cell line NS0­derived recombinant human Cathepsin A/Lysosomal Carboxypeptidase A Ala29­Tyr480 (predicted) Accession # P10619 Formulation Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. See Certificate of Analysis for details. *Small pack size (­SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS. APPLICATIONS Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website. Recommended Sample Concentration Western Blot 1 µg/mL Recombinant Human Cathepsin A/Lysosomal Carboxypeptidase A (Catalog # 1049­SE) Immunoprecipitation 25 µg/mL Conditioned cell culture medium spiked with Recombinant Human Cathepsin A/Lysosomal Carboxypeptidase A (Catalog # 1049­SE), see our available Western blot detection antibodies PREPARATION AND STORAGE Reconstitution Reconstitute at 0.5 mg/mL in sterile PBS. Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
    [Show full text]
  • Mechanisms Governing Anaphylaxis: Inflammatory Cells, Mediators
    International Journal of Molecular Sciences Review Mechanisms Governing Anaphylaxis: Inflammatory Cells, Mediators, Endothelial Gap Junctions and Beyond Samantha Minh Thy Nguyen 1, Chase Preston Rupprecht 2, Aaisha Haque 3, Debendra Pattanaik 4, Joseph Yusin 5 and Guha Krishnaswamy 1,3,* 1 Department of Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27106, USA; [email protected] 2 The Rowan School of Osteopathic Medicine, Stratford, NJ 08084, USA; [email protected] 3 The Bill Hefner VA Medical Center, Salisbury, NC 27106, USA; [email protected] 4 Division of Allergy and Immunology, UT Memphis College of Medicine, Memphis, TN 38103, USA; [email protected] 5 The Division of Allergy and Immunology, Greater Los Angeles VA Medical Center, Los Angeles, CA 90011, USA; [email protected] * Correspondence: [email protected] Abstract: Anaphylaxis is a severe, acute, life-threatening multisystem allergic reaction resulting from the release of a plethora of mediators from mast cells culminating in serious respiratory, cardiovascular and mucocutaneous manifestations that can be fatal. Medications, foods, latex, exercise, hormones (progesterone), and clonal mast cell disorders may be responsible. More recently, novel syndromes such as delayed reactions to red meat and hereditary alpha tryptasemia have been described. Anaphylaxis manifests as sudden onset urticaria, pruritus, flushing, erythema, Citation: Nguyen, S.M.T.; Rupprecht, angioedema (lips, tongue, airways, periphery), myocardial dysfunction (hypovolemia, distributive
    [Show full text]
  • Expanding the Genetic Basis of Copy Number Variation in Familial Breast
    Masson et al. Hereditary Cancer in Clinical Practice 2014, 12:15 http://www.hccpjournal.com/content/12/1/15 RESEARCH Open Access Expanding the genetic basis of copy number variation in familial breast cancer Amy L Masson1,4, Bente A Talseth-Palmer1,4, Tiffany-Jane Evans1,4, Desma M Grice1,2, Garry N Hannan2 and Rodney J Scott1,3,4* Abstract Introduction: Familial breast cancer (fBC) is generally associated with an early age of diagnosis and a higher frequency of disease among family members. Over the past two decades a number of genes have been identified that are unequivocally associated with breast cancer (BC) risk but there remain a significant proportion of families that cannot be accounted for by these genes. Copy number variants (CNVs) are a form of genetic variation yet to be fully explored for their contribution to fBC. CNVs exert their effects by either being associated with whole or partial gene deletions or duplications and by interrupting epigenetic patterning thereby contributing to disease development. CNV analysis can also be used to identify new genes and loci which may be associated with disease risk. Methods: The Affymetrix Cytogenetic Whole Genome 2.7 M (Cyto2.7 M) arrays were used to detect regions of genomic re-arrangement in a cohort of 129 fBC BRCA1/BRCA2 mutation negative patients with a young age of diagnosis (<50 years) compared to 40 unaffected healthy controls (>55 years of age). Results: CNV analysis revealed the presence of 275 unique rearrangements that were not present in the control population suggestive of their involvement in BC risk.
    [Show full text]
  • Identification and Interaction Analysis of Molecular Markers in Pancreatic
    medRxiv preprint doi: https://doi.org/10.1101/2020.12.20.20248601; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification and Interaction Analysis of Molecular Markers in Pancreatic Ductal Adenocarcinoma by Integrated Bioinformatics Analysis and Molecular Docking Experiments Basavaraj Vastrad1 , Chanabasayya Vastrad *2, Anandkumar Tengli3 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics,Chanabasava Nilaya, Bharthinagar, Dharwad, Karanataka 580001, India. 3. Department of Pharmaceutical Chemistry, JSS College of Pharmacy, Mysuru and JSS Academy of Higher Education & Research, Mysuru- 570015, Karnataka, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.20.20248601; this version posted December 23, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract The current investigation aimed to mine therapeutic molecular targets that play an key part in the advancement of pancreatic ductal adenocarcinoma (PDAC). The expression profiling by high throughput sequencing dataset profile GSE133684 dataset was downloaded from the Gene Expression Omnibus (GEO) database.
    [Show full text]
  • The Dual Role of Myeloperoxidase in Immune Response
    International Journal of Molecular Sciences Review The Dual Role of Myeloperoxidase in Immune Response Jürgen Arnhold Institute of Medical Physics and Biophysics, Medical Faculty, Leipzig University, 04 107 Leipzig, Germany; [email protected] Received: 5 October 2020; Accepted: 28 October 2020; Published: 29 October 2020 Abstract: The heme protein myeloperoxidase (MPO) is a major constituent of neutrophils. As a key mediator of the innate immune system, neutrophils are rapidly recruited to inflammatory sites, where they recognize, phagocytose, and inactivate foreign microorganisms. In the newly formed phagosomes, MPO is involved in the creation and maintenance of an alkaline milieu, which is optimal in combatting microbes. Myeloperoxidase is also a key component in neutrophil extracellular traps. These helpful properties are contrasted by the release of MPO and other neutrophil constituents from necrotic cells or as a result of frustrated phagocytosis. Although MPO is inactivated by the plasma protein ceruloplasmin, it can interact with negatively charged components of serum and the extracellular matrix. In cardiovascular diseases and many other disease scenarios, active MPO and MPO-modified targets are present in atherosclerotic lesions and other disease-specific locations. This implies an involvement of neutrophils, MPO, and other neutrophil products in pathogenesis mechanisms. This review critically reflects on the beneficial and harmful functions of MPO against the background of immune response. Keywords: myeloperoxidase; neutrophils; immune response; phagosomes; cardiovascular diseases; chronic inflammation 1. Immune Response and Tissue Destruction In humans and higher animals, protection against different threats that affect the homeostasis of host’s tissues is ensured by a coordinated action of the immune system in close association with activation of components of the acute phase, complement, coagulation, and contact systems [1,2].
    [Show full text]
  • Expressed Sequence Tag Analysis of the Response of Apple
    Physiologia Plantarum 133: 298–317. 2008 Copyright ª Physiologia Plantarum 2008, ISSN 0031-9317 Expressed sequence tag analysis of the response of apple (Malus x domestica ‘Royal Gala’) to low temperature and water deficit Michael Wisniewskia,*, Carole Bassetta,*, John Norellia, Dumitru Macarisina, Timothy Artlipa, Ksenija Gasicb and Schuyler Korbanb aUnited States Department of Agriculture – Agricultural Research Service (USDA-ARS), Appalachian Fruit Research Station, 2217 Wiltshire Road, Kearneysville, WV 25430, USA bDepartment of Natural Resources and Environmental Sciences, University of Illinois, 310 ERML, 1201 W. Gregory Drive, Urbana, IL 61801, USA Correspondence Leaf, bark, xylem and root tissues were used to make nine cDNA libraries from *Corresponding author, non-stressed (control) ‘Royal Gala’ apple trees, and from ‘Royal Gala’ trees e-mail: [email protected]; exposed to either low temperature (5°C for 24 h) or water deficit (45% of [email protected] saturated pot mass for 2 weeks). Over 22 600 clones from the nine libraries # Received 26 September 2007; revised 3 were subjected to 5 single-pass sequencing, clustered and annotated using January 2008 BLASTX. The number of clusters in the libraries ranged from 170 to 1430. Regarding annotation of the sequences, BLASTX analysis indicated that within doi: 10.1111/j.1399-3054.2008.01063.x the libraries 65–72% of the clones had a high similarity to known function genes, 6–15% had no functional assignment and 15–26% were completely novel. The expressed sequence tags were combined into three classes (control, low-temperature and water deficit) and the annotated genes in each class were placed into 1 of 10 different functional categories.
    [Show full text]
  • In Sickness and in Health: the Immunological Roles of the Lymphatic System
    International Journal of Molecular Sciences Review In Sickness and in Health: The Immunological Roles of the Lymphatic System Louise A. Johnson MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DS, UK; [email protected] Abstract: The lymphatic system plays crucial roles in immunity far beyond those of simply providing conduits for leukocytes and antigens in lymph fluid. Endothelial cells within this vasculature are dis- tinct and highly specialized to perform roles based upon their location. Afferent lymphatic capillaries have unique intercellular junctions for efficient uptake of fluid and macromolecules, while expressing chemotactic and adhesion molecules that permit selective trafficking of specific immune cell subsets. Moreover, in response to events within peripheral tissue such as inflammation or infection, soluble factors from lymphatic endothelial cells exert “remote control” to modulate leukocyte migration across high endothelial venules from the blood to lymph nodes draining the tissue. These immune hubs are highly organized and perfectly arrayed to survey antigens from peripheral tissue while optimizing encounters between antigen-presenting cells and cognate lymphocytes. Furthermore, subsets of lymphatic endothelial cells exhibit differences in gene expression relating to specific func- tions and locality within the lymph node, facilitating both innate and acquired immune responses through antigen presentation, lymph node remodeling and regulation of leukocyte entry and exit. This review details the immune cell subsets in afferent and efferent lymph, and explores the mech- anisms by which endothelial cells of the lymphatic system regulate such trafficking, for immune surveillance and tolerance during steady-state conditions, and in response to infection, acute and Citation: Johnson, L.A.
    [Show full text]
  • The CXCR4 Antagonist AMD3100 Impairs Survival of Human AML Cells and Induces Their Differentiation
    Leukemia (2008) 22, 2151–2158 & 2008 Macmillan Publishers Limited All rights reserved 0887-6924/08 $32.00 www.nature.com/leu ORIGINAL ARTICLE The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation S Tavor1, M Eisenbach1, J Jacob-Hirsch2, T Golan1, I Petit1, K BenZion1, S Kay1, S Baron1, N Amariglio2, V Deutsch1, E Naparstek1 and G Rechavi2 1Institute of Hematology and Bone Marrow Transplantation, Sourasky Medical Center, Tel Aviv, Israel and 2Cancer Research Center, Sheba Medical Center, Tel-Hashomer, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel The chemokine stromal cell-derived factor-1 (SDF-1) and its NOD/SCID mice, homing and subsequent engraftment of human receptor, CXCR4, participate in the retention of acute myelo- normal or AML stem cells are dependent on the expression of cell blastic leukemia (AML) cells within the bone marrow micro- 9–12 environment and their release into the circulation. AML cells surface CXCR4 and SDF-1 produced within the murine. In also constitutively express SDF-1-dependent elastase, which addition to controlling cell motility, SDF-1 regulates cell regulates their migration and proliferation. To study the proliferation, induces cell cycle progression and acts as a survival molecular events and genes regulated by the SDF-1/CXCR4 factor for normal human stem cells and AML cells.13–16 axis and elastase in AML cells, we examined gene expression CXCR4 blockage in AML cells, using the polypeptide profiles of the AML cell line, U937, under treatment with a RCP168, enhanced chemotherapy-induced apoptosis in vitro.17 neutralizing anti-CXCR4 antibody or elastase inhibitor, as compared with non-treated cells, using DNA microarray Most importantly, high CXCR4 expression level in leukemic technology.
    [Show full text]
  • A Novel Method of Neural Differentiation of PC12 Cells by Using Opti-MEM As a Basic Induction Medium
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 41: 195-201, 2018 A novel method of neural differentiation of PC12 cells by using Opti-MEM as a basic induction medium RENDONG HU1*, QIAOYU CAO2*, ZHONGQING SUN3, JINYING CHEN4, QING ZHENG2 and FEI XIAO1 1Department of Pharmacology, School of Medicine, Jinan University; 2College of Pharmacy, Jinan University, Guangzhou, Guangdong 510632; 3Department of Anesthesia and Intensive Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong 999077, SAR; 4Department of Ophthalmology, The First Clinical Medical College of Jinan University, Guangzhou, Guangdong 510632, P.R. China Received April 5, 2017; Accepted October 11, 2017 DOI: 10.3892/ijmm.2017.3195 Abstract. The PC12 cell line is a classical neuronal cell model Introduction due to its ability to acquire the sympathetic neurons features when deal with nerve growth factor (NGF). In the present study, The PC12 cell line is traceable to a pheochromocytoma from the authors used a variety of different methods to induce PC12 the rat adrenal medulla (1-4). When exposed to nerve growth cells, such as Opti-MEM medium containing different concen- factor (NGF), PC12 cells present an observable change in trations of fetal bovine serum (FBS) and horse serum compared sympathetic neuron phenotype and properties. Neural differ- with RPMI-1640 medium, and then observed the neurite length, entiation of PC12 has been widely used as a neuron cell model differentiation, adhesion, cell proliferation and action poten- in neuroscience, such as in the nerve injury-induced neuro- tial, as well as the protein levels of axonal growth-associated pathic pain model (5) and nitric oxide-induced neurotoxicity protein 43 (GAP-43) and synaptic protein synapsin-1, among model (6).
    [Show full text]
  • Fluid Biomarkers for Synaptic Dysfunction and Loss
    BMI0010.1177/1177271920950319Biomarker InsightsCamporesi et al 950319review-article2020 Biomarker Insights Fluid Biomarkers for Synaptic Dysfunction and Loss Volume 15: 1–17 © The Author(s) 2020 Elena Camporesi1 , Johanna Nilsson1, Ann Brinkmalm1, Article reuse guidelines: sagepub.com/journals-permissions 1,2 1,3,4,5 1,2 Bruno Becker , Nicholas J Ashton , Kaj Blennow DOI:https://doi.org/10.1177/1177271920950319 10.1177/1177271920950319 and Henrik Zetterberg1,2,6,7 1Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 2Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden. 3King’s College London, Institute of Psychiatry, Psychology & Neuroscience, The Maurice Wohl Clinical Neuroscience Institute, London, UK. 4NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation, London, UK. 5Wallenberg Centre for Molecular and Translational Medicine, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 6Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK. 7UK Dementia Research Institute at UCL, London, UK. ABSTRACT: Synapses are the site for brain communication where information is transmitted between neurons and stored for memory forma- tion. Synaptic degeneration is a global and early pathogenic event in neurodegenerative
    [Show full text]